Get started
Artelo Biosciences, Inc.Artelo Biosciences, Inc.Artelo Biosciences, Inc.

Artelo Biosciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ARTL chart


Full chart

ARTL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.10 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.8447 USD
Net income (FY)
‪−9.29 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪3.20 M‬
Beta (1Y)
0.81

Employees


Employees (FY)
6
Change (1Y)
−1 −14.29%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.55 M‬ USD

About Artelo Biosciences, Inc.


Sector
Health Technology
CEO
Gregory D. Gorgas
Headquarters
Solana Beach
Website
artelobio.com
Founded
2011
FIGI
BBG00793XCW0
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ARTL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ARTL is 0.9700 USD — it has increased by 1.04% in the past 24 hours. Watch Artelo Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Artelo Biosciences, Inc. stocks are traded under the ticker ARTL.
ARTL stock has fallen by −7.62% compared to the previous week, the month change is a −15.90% fall, over the last year Artelo Biosciences, Inc. has showed a −26.52% decrease.
We've gathered analysts' opinions on Artelo Biosciences, Inc. future price: according to them, ARTL price has a max estimate of 6.00 USD and a min estimate of 4.00 USD. Watch ARTL chart and read a more detailed Artelo Biosciences, Inc. stock forecast: see what analysts think of Artelo Biosciences, Inc. and suggest that you do with its stocks.
ARTL reached its all-time high on Feb 12, 2018 with the price of 300.0000 USD, and its all-time low was 0.9100 USD and was reached on Dec 20, 2024. View more price dynamics on ARTL chart.
See other stocks reaching their highest and lowest prices.
ARTL stock is 3.61% volatile and has beta coefficient of 0.81. Track Artelo Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Artelo Biosciences, Inc. there?
Today Artelo Biosciences, Inc. has the market capitalization of ‪3.10 M‬, it has decreased by −5.88% over the last week.
Yes, you can track Artelo Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Artelo Biosciences, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ARTL earnings for the last quarter are −0.35 USD per share, whereas the estimation was −0.79 USD resulting in a 55.84% surprise. The estimated earnings for the next quarter are −0.36 USD per share. See more details about Artelo Biosciences, Inc. earnings.
Artelo Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ARTL net income for the last quarter is ‪−1.13 M‬ USD, while the quarter before that showed ‪−2.43 M‬ USD of net income which accounts for 53.47% change. Track more Artelo Biosciences, Inc. financial stats to get the full picture.
No, ARTL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 6.00 employees. See our rating of the largest employees — is Artelo Biosciences, Inc. on this list?
Like other stocks, ARTL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Artelo Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Artelo Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Artelo Biosciences, Inc. stock shows the sell signal. See more of Artelo Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.